Macrophage inhibitory cytokine-1 (MIC-1) participates in cancer, stroke and heart attack. Studies show that measurement of MIC-1 in blood and cancer tissue might be useful to detect the development of cancer and determine whether it will spread. Also, MIC-1 measurement can identify people who are at risk of dying of cancer, heart attack and stroke. This study will show how MIC-1 may be used to prevent, diagnose and help treat these conditions and reduce healthcare costs.
Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15), CCAAT/enhancer Binding Protein Delta (CEBPD) And Neuroinflammtion
Funder
National Health and Medical Research Council
Funding Amount
$459,270.00
Summary
I will develop new therapies for multiple sclerosis and spinal cord injury. I will also evaluate diagnostic and therapeutic uses for macrophage inhibitory cytokine-1 (MIC-1/GDF15) that was discovered in Australia. I will confirm its use in screening for bowel cancer. Also, I will look at using it in the indigenous and wider Australian community to improve health and close the gap in life expectancy. Finally, I will conduct trials of MIC-1/GDF15 therapy of obesity and inflammation.